American Cryostem Corp - ESG Rating & Company Profile powered by AI
Other companies in the scoring industry group for American Cryostem Corp are displayed. This page includes a questions and answers section on American Cryostem Corp. This assessment of American Cryostem Corp is assembled by All Street Sevva using leading Cognitive Robots.
American Cryostem Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | American Cryostem Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does American Cryostem Corp have an accelerator or VC vehicle to help deliver innovation?
Does American Cryostem Corp disclose current and historical energy intensity?
Does American Cryostem Corp report the average age of the workforce?
Does American Cryostem Corp reference operational or capital allocation in relation to climate change?
Does American Cryostem Corp disclose its ethnicity pay gap?
Does American Cryostem Corp disclose cybersecurity risks?
Does American Cryostem Corp offer flexible work?
Does American Cryostem Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does American Cryostem Corp disclose the number of employees in R&D functions?
Does American Cryostem Corp conduct supply chain audits?
Does American Cryostem Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does American Cryostem Corp conduct 360 degree staff reviews?
Does American Cryostem Corp disclose the individual responsible for D&I?
Does American Cryostem Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does American Cryostem Corp disclose current and / or historical scope 2 emissions?
Does American Cryostem Corp disclose water use targets?
Does American Cryostem Corp have careers partnerships with academic institutions?
Did American Cryostem Corp have a product recall in the last two years?
Does American Cryostem Corp disclose incidents of discrimination?
Does American Cryostem Corp allow for Work Councils/Collective Agreements to be formed?
Has American Cryostem Corp issued a profit warning in the past 24 months?
Does American Cryostem Corp disclose parental leave metrics?
Does American Cryostem Corp disclose climate scenario or pathway analysis?
Does American Cryostem Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does American Cryostem Corp disclose the pay ratio of women to men?
Does American Cryostem Corp support suppliers with sustainability related research and development?
Does American Cryostem Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does American Cryostem Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is American Cryostem Corp involved in embryonic stem cell research?
Does American Cryostem Corp disclose GHG and Air Emissions intensity?
Does American Cryostem Corp disclose its waste policy?
Does American Cryostem Corp report according to TCFD requirements?
Does American Cryostem Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does American Cryostem Corp disclose energy use targets?
Does American Cryostem Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does American Cryostem Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for American Cryostem Corp
These potential risks are based on the size, segment and geographies of the company.
American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.